Logos Global Management Lp - Net Worth and Insider Trading
Logos Global Management Lp Net Worth
The estimated net worth of Logos Global Management Lp is at least $33 Million dollars as of 2024-09-20. Logos Global Management Lp is the 10% Owner of Dynegy Inc and owns about 1,504,392 shares of Dynegy Inc (DYN) stock worth over $28 Million. Logos Global Management Lp is the 10% Owner of Verve Therapeutics Inc and owns about 813,265 shares of Verve Therapeutics Inc (VERV) stock worth over $4 Million. Logos Global Management Lp is also the 10% Owner of Eledon Pharmaceuticals Inc and owns about 224,071 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $555,696. Details can be seen in Logos Global Management Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Logos Global Management Lp has not made any transactions after 2021-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Logos Global Management Lp
Logos Global Management Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Logos Global Management Lp owns 3 companies in total, including Dyne Therapeutics Inc (DYN) , Eledon Pharmaceuticals Inc (ELDN) , and Verve Therapeutics Inc (VERV) .
Click here to see the complete history of Logos Global Management Lp’s form 4 insider trades.
Insider Ownership Summary of Logos Global Management Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DYN | Dyne Therapeutics Inc | 2020-09-16 | 10 percent owner |
| ELDN | Eledon Pharmaceuticals Inc | 2020-10-30 | 10 percent owner |
| VERV | Verve Therapeutics Inc | 2021-06-21 | 10 percent owner |
Logos Global Management Lp Latest Holdings Summary
Logos Global Management Lp currently owns a total of 3 stocks. Among these stocks, Logos Global Management Lp owns 1,504,392 shares of Dynegy Inc (DYN) as of September 21, 2020, with a value of $28 Million and a weighting of 85%. Logos Global Management Lp owns 813,265 shares of Verve Therapeutics Inc (VERV) as of June 21, 2021, with a value of $4 Million and a weighting of 13.31%. Logos Global Management Lp also owns 224,071 shares of Eledon Pharmaceuticals Inc (ELDN) as of October 30, 2020, with a value of $555,696 and a weighting of 1.69%.
Latest Holdings of Logos Global Management Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DYN | Dynegy Inc | 2020-09-21 | 1,504,392 | 18.61 | 27,996,735 |
| VERV | Verve Therapeutics Inc | 2021-06-21 | 813,265 | 5.39 | 4,383,498 |
| ELDN | Eledon Pharmaceuticals Inc | 2020-10-30 | 224,071 | 2.48 | 555,696 |
Holding Weightings of Logos Global Management Lp
Logos Global Management Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Logos Global Management Lp has made a total of 1 transactions in Dynegy Inc (DYN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Dynegy Inc is the acquisition of 700,000 shares on September 21, 2020, which cost Logos Global Management Lp around $13 Million.
According to the SEC Form 4 filings, Logos Global Management Lp has made a total of 1 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Verve Therapeutics Inc is the acquisition of 370,000 shares on June 21, 2021, which cost Logos Global Management Lp around $7 Million.
According to the SEC Form 4 filings, Logos Global Management Lp has made a total of 2 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the sale of 12,969 shares on October 30, 2020, which brought Logos Global Management Lp around $345,494.
Insider Trading History of Logos Global Management Lp
- 1
Logos Global Management Lp Trading Performance
GuruFocus tracks the stock performance after each of Logos Global Management Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Logos Global Management Lp is -4.29%. GuruFocus also compares Logos Global Management Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Logos Global Management Lp within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Logos Global Management Lp's insider trading performs compared to the benchmark.
Performance of Logos Global Management Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.88 | | | | | |
| Relative Return to S&P 500(%) | 12.92 | | | | | |
Logos Global Management Lp Ownership Network
Logos Global Management Lp Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Logos Global Management Lp is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , Chief Operating Officer Susanna Gatti High , and See Remarks Oxana Beskrovnaya .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Logos Global Management Lp made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 327,516 shares made by Richard William Scalzo , a net sale of 273,683 shares made by Susanna Gatti High , and a net sale of 140,498 shares made by Oxana Beskrovnaya .
In summary, during the past 3 months, insiders sold 2,080,955 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 2,048,955 shares. During the past 18 months, 7,664,687 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 5,918,402 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Logos Global Management Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Logos Global Management Lp. You might contact Logos Global Management Lp via mailing address: 1 Letterman Drive, Bldg C, Suite C3-350, San Francisco Ca 94129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
